Key result
A 36-year-old male presented with a rare co-occurrence of acute STEMI and very severe hypertriglyceridemia (2,700 mg/dL) complicated by suspected pancreatitis.
Why the study?
Acute STEMI is an uncommonly known co-presentation of hypertriglyceridemia, with the literature citing only one other case of acute STEMI complicated by very severe hypertriglyceridemia.
Case Report (n=1)
Highlights a rare co-presentation of acute STEMI and very severe hypertriglyceridemia, emphasizing the need for early detection and intervention.
Hypertriglyceridemia (HTG) is the elevation of serum triglyceride levels above 150 mg/dL and is linked to complications such as pancreatitis and increased mortality risk. An uncommonly known co-presentation of HTG is acute ST-elevation myocardial infarction (STEMI), with the literature citing only one other case of acute STEMI complicated by very severe HTG. We report on a 36-year-old male with multiple comorbidities presenting with acute STEMI and elevated pancreatic enzymes suggestive of pancreatitis. A subsequent lipid profile revealed very severe HTG with a triglyceride level of 2,700 mg/dL. We discuss the pathogenesis, management, and screening guidelines of very severe HTG. Clinicians should be aware that acute STEMI complicated by HTG is rare and that earlier detection and intervention may allow for the prevention of life-threatening complications.
No takes yet. Share an insight, caveat, or question.
Wu et al. (2020) conducted a case report in Acute STEMI and very severe hypertriglyceridemia (n=1). Very severe hypertriglyceridemia was evaluated. A 36-year-old male presented with a rare co-occurrence of acute STEMI and very severe hypertriglyceridemia (2,700 mg/dL) complicated by suspected pancreatitis.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: